Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I–III Mucinous Colorectal Adenocarcinoma

References

• Luo C , Cen S , Ding G , Wu W . Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun . 2019;39(1):13. doi:10.1186/s40880-019-0361-0
   Web of Science ®Google Scholar
• Gao P , Song YX , Xu YY , et al. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases. Histopathology . 2013;63(5):603–615. doi:10.1111/his.12190 23991632
   PubMed Web of Science ®Google Scholar
• Kim SH , Shin SJ , Lee KY , et al. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study. Ann Surg Oncol . 2013;20(11):3407–3413. doi:10.1245/s10434-013-3169-1 23943026
   PubMed Web of Science ®Google Scholar
• Coussens LM , Werb Z . Inflammation and cancer. Nature . 2002;420(6917):860–867. doi:10.1038/nature01322 12490959
   PubMed Web of Science ®Google Scholar
• Hugen N , van Beek JJ , de Wilt JH , Nagtegaal ID . Insight into mucinous colorectal carcinoma: clues from etiology. Ann Surg Oncol . 2014;21(9):2963–2970. doi:10.1245/s10434-014-3706-6 24728741
   PubMed Web of Science ®Google Scholar
• Drew DA , Cao Y , Chan AT . Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer . 2016;16(3):173–186. doi:10.1038/nrc.2016.4 26868177
   PubMed Web of Science ®Google Scholar
• Sun F , Tan YA , Gao QF , et al. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer. J Clin Lab Anal . 2019;33(1):e22635. doi:10.1002/jcla.22635 30047185
   PubMed Web of Science ®Google Scholar
• Sun F , Peng HX , Gao QF , et al. Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II-III colorectal cancer patients. Cancer Manag Res . 2018;10:2151–2161. doi:10.2147/CMAR.S167398 30050325
   PubMed Web of Science ®Google Scholar
• Guo X , Zou Q , Yan J , Zhen X , Gu H . Prognostic effect of pretreatment albumin-to-alkaline phosphatase ratio in human cancers: a meta-analysis. PLoS One . 2020;15(8):e0237793. doi:10.1371/journal.pone.0237793 32822383
   PubMed Web of Science ®Google Scholar
• Tingle SJ , Severs GR , Goodfellow M , Moir JA , White SA . NARCA: a novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer. J Surg Oncol . 2018;118(4):680–686. doi:10.1002/jso.25209 30196571
   PubMed Web of Science ®Google Scholar
• Chi J , Xie Q , Jia J , et al. Prognostic Value of Albumin/Globulin Ratio in Survival and Lymph Node Metastasis in Patients with Cancer: a Systematic Review and Meta-analysis. J Cancer . 2018;9(13):2341–2348. doi:10.7150/jca.24889 30026830
   PubMed Web of Science ®Google Scholar
• Li SQ , You XH , Sun F , et al. Albumin to fibrinogen ratio and fibrinogen to pre-albumin ratio are economical, simple and promising prognostic factors for solid malignancy. J Thorac Dis . 2019;11(Suppl15):S2036–S2038. doi:10.21037/jtd.2019.08.96 31632821
   PubMed Web of Science ®Google Scholar
• Zhang J , Li SQ , Liao ZH , et al. Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer. Oncotarget . 2017;8(43):75195–75205. doi:10.18632/oncotarget.20661 29088857
   PubMedGoogle Scholar
• Li SQ , Jiang YH , Lin J , et al. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals. Cancer Med . 2018;7(4):1221–1231. doi:10.1002/cam4.1428 29533009
   PubMed Web of Science ®Google Scholar
• Gao QF , Qiu JC , Huang XH , et al. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy. Cancer Cell Int . 2018;18:153. doi:10.1186/s12935-018-0648-2 30305803
   PubMed Web of Science ®Google Scholar
• Chen QG , Zhang L , Sun F , et al. Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients. Aging . 2019;11(6):1716–1732. doi:10.18632/aging.101864 30897064
   PubMedGoogle Scholar
• Pande R , Sunga A , Levea C , et al. Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum . 2008;51(1):50–55. doi:10.1007/s10350-007-9073-7 18030531
   PubMed Web of Science ®Google Scholar
• Papadopoulos VN , Michalopoulos A , Netta S , et al. Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol . 2004;8(Suppl 1):s123–5. doi:10.1007/s10151-004-0131-z 15655594
   PubMedGoogle Scholar
• Yu F , Huang L , Shen F , Wu S , Chen J . Prognostic implications of mucinous histology in stage III colon cancer with the receipt of adjuvant chemotherapy. J Gastrointest Oncol . 2020;11(5):858–869. doi:10.21037/jgo-20-160 33209482
   PubMed Web of Science ®Google Scholar
• Ahnen DJ , Wade SW , Jones WF , et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc . 2014;89(2):216–224. doi:10.1016/j.mayocp.2013.09.006 24393412
   PubMed Web of Science ®Google Scholar
• Song W , He YL , Cai SR , et al. [Clinical features of colorectal mucinous adenocarcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi . 2009;12(5):487–490. Chinese.19742341
   PubMedGoogle Scholar
• Liao YC , Ying HQ , Sun F , Peng HX . The role of cancer-elicited inflammatory biomarkers in predicting early recurrence within stage II-III colorectal cancer patients after curable resection. J Inflamm Res . 2021;14:115–129.33500648
   PubMed Web of Science ®Google Scholar
• Triki M , Kallel R , Feki J , et al. Prognostic significance of E-cadherin and Cox 2 expression in Tunisian patients with colorectal mucinous adenocarcinoma. Ann Diagn Pathol . 2020;49:151624. doi:10.1016/j.anndiagpath.2020.151624 32919337
   PubMed Web of Science ®Google Scholar
• Li ZP , Liu XY , Kao XM , et al. Clinicopathological characteristics and prognosis of colorectal mucinous adenocarcinoma and nonmucinous adenocarcinoma: a surveillance, epidemiology, and end results (SEER) population-based study. Ann Transl Med . 2020;8(5):205. doi:10.21037/atm.2020.01.52 32309352
   PubMed Web of Science ®Google Scholar
• Huang Q , Zou MH , Jiang Y , et al. Outcomes of Laparoscopic Surgery for Mucinous Colorectal Adenocarcinoma. J Laparoendosc Adv Surg Tech A . 2020. doi:10.1089/lap.2020.0588
   Web of Science ®Google Scholar
• Malietzis G , Giacometti M , Askari A , et al. A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg . 2014;260(2):287–292. doi:10.1097/SLA.0000000000000216 24096764
   PubMed Web of Science ®Google Scholar
• Ying HQ , Deng QW , He BS , et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol . 2014;31(12):305. doi:10.1007/s12032-014-0305-0 25355641
   PubMed Web of Science ®Google Scholar
• Reynolds IS , Thomas V , O’Connell E , et al. Mucinous Adenocarcinoma of the Rectum: a Whole Genome Sequencing Study. Front Oncol . 2020;10:1682. doi:10.3389/fonc.2020.01682 32984045
   PubMed Web of Science ®Google Scholar